Alkermes (ALKS) Shares Outstanding (Weighted Average) (2010 - 2026)

Alkermes (ALKS) reported Shares Outstanding (Weighted Average) of $166.2 million for Q1 2026, up 1.71% year-over-year from $163.4 million in Q1 2025, and up 0.91% quarter-over-quarter from $164.7 million in Q4 2025.

Alkermes (ALKS) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $166.2 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $166.2 million, up 1.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $166.2 million (up 1.71% YoY), and the FY2025 annual result was $164.7 million, changed 0.42% from the prior year.
  • Shares Outstanding (Weighted Average) improved to $166.2 million in Q1 2026 per ALKS's latest filing, from $164.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $168.2 million in Q2 2024 and troughed at $162.5 million in Q1 2022.
  • A 5-year average of $165.2 million and a median of $165.1 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) grew 1.87% in 2023, then dropped 2.72% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $163.7 million in 2022, then grew by 1.52% to $166.2 million in 2023, then dropped by 0.5% to $165.4 million in 2024, then fell by 0.42% to $164.7 million in 2025, then grew by 0.91% to $166.2 million in 2026.
  • Business Quant data shows ALKS's Shares Outstanding (Weighted Average) at $166.2 million in Q1 2026, $164.7 million in Q4 2025, and $164.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 88.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 166.20 Mn
Dec 31, 2025 164.70 Mn
Sep 30, 2025 164.49 Mn
Jun 30, 2025 164.19 Mn
Mar 31, 2025 163.41 Mn
Dec 31, 2024 165.39 Mn
Sep 30, 2024 166.55 Mn
Jun 30, 2024 168.15 Mn
Mar 31, 2024 167.98 Mn
Dec 31, 2023 166.22 Mn
Sep 30, 2023 166.61 Mn
Jun 30, 2023 165.69 Mn
Mar 31, 2023 165.09 Mn
Dec 31, 2022 163.74 Mn
Sep 30, 2022 163.54 Mn
Jun 30, 2022 163.17 Mn
Mar 31, 2022 162.48 Mn
Dec 31, 2021 160.94 Mn
Sep 30, 2021 161.46 Mn
Jun 30, 2021 160.82 Mn